94 related articles for article (PubMed ID: 22624650)
1. Identification of a novel structure in heparin generated by sequential oxidative-reductive treatment.
Beccati D; Roy S; Lech M; Ozug J; Schaeck J; Gunay NS; Zouaoui R; Capila I; Kaundinya GV
Anal Chem; 2012 Jun; 84(11):5091-6. PubMed ID: 22624650
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic preparation of heparin disaccharides as building blocks in glycosaminoglycan synthesis.
Kim YS; Thanawiroon C; Bazin HG; Kerns RJ; Linhard RJ
Prep Biochem Biotechnol; 2001 May; 31(2):113-24. PubMed ID: 11426699
[TBL] [Abstract][Full Text] [Related]
3. Characterization of currently marketed heparin products: reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests.
Brustkern AM; Buhse LF; Nasr M; Al-Hakim A; Keire DA
Anal Chem; 2010 Dec; 82(23):9865-70. PubMed ID: 21069966
[TBL] [Abstract][Full Text] [Related]
4. Heparin sodium compliance to the new proposed USP monograph: elucidation of a minor structural modification responsible for a process dependent 2.10 ppm NMR signal.
Mourier PA; Guichard OY; Herman F; Viskov C
J Pharm Biomed Anal; 2011 Jan; 54(2):337-44. PubMed ID: 20934294
[TBL] [Abstract][Full Text] [Related]
5. Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin.
Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugiura M; Sugahara K
Biochemistry; 1999 Jan; 38(2):838-47. PubMed ID: 9888825
[TBL] [Abstract][Full Text] [Related]
6. Identification of heparin oligosaccharides by direct coupling of capillary electrophoresis/ionspray-mass spectrometry.
Duteil S; Gareil P; Girault S; Mallet A; Feve C; Siret L
Rapid Commun Mass Spectrom; 1999; 13(19):1889-98. PubMed ID: 10487934
[TBL] [Abstract][Full Text] [Related]
7. Crude Heparin Preparations Unveil the Presence of Structurally Diverse Oversulfated Contaminants.
Mendes A; Meneghetti MCZ; Palladino MV; Justo GZ; Sassaki GL; Fareed J; Lima MA; Nader HB
Molecules; 2019 Aug; 24(16):. PubMed ID: 31426507
[TBL] [Abstract][Full Text] [Related]
8. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
[TBL] [Abstract][Full Text] [Related]
9. Case study: contamination of heparin with oversulfated chondroitin sulfate.
Chess EK; Bairstow S; Donovan S; Havel K; Hu P; Johnson RJ; Lee S; McKee J; Miller R; Moore E; Nordhaus M; Ray J; Szabo C; Wielgos T
Handb Exp Pharmacol; 2012; (207):99-125. PubMed ID: 22566223
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of unfractionated heparins studied in connection with species, source, and production processes.
Bianchini P; Liverani L; Mascellani G; Parma B
Semin Thromb Hemost; 1997; 23(1):3-10. PubMed ID: 9156404
[TBL] [Abstract][Full Text] [Related]
11. Characterization of oligosaccharides from the chondroitin/dermatan sulfates. 1H-NMR and 13C-NMR studies of reduced trisaccharides and hexasaccharides.
Huckerby TN; Nieduszynski IA; Giannopoulos M; Weeks SD; Sadler IH; Lauder RM
FEBS J; 2005 Dec; 272(24):6276-86. PubMed ID: 16336265
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248
[TBL] [Abstract][Full Text] [Related]
13. Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application.
Hu P; Fang L; Chess EK
Anal Chem; 2009 Mar; 81(6):2332-43. PubMed ID: 19228018
[TBL] [Abstract][Full Text] [Related]
14. Mapping critical biological motifs and biosynthetic pathways of heparan sulfate.
Lawrence R; Kuberan B; Lech M; Beeler DL; Rosenberg RD
Glycobiology; 2004 May; 14(5):467-79. PubMed ID: 15033939
[TBL] [Abstract][Full Text] [Related]
15. Construction and use of a library of bona fide heparins employing 1H NMR and multivariate analysis.
Rudd TR; Gaudesi D; Skidmore MA; Ferro M; Guerrini M; Mulloy B; Torri G; Yates EA
Analyst; 2011 Apr; 136(7):1380-9. PubMed ID: 21279243
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of depolymerized heparin SEC fractions: to pool or not to pool?
Eldridge SL; Korir AK; Gutierrez SM; Campos F; Limtiaco JF; Larive CK
Carbohydr Res; 2008 Nov; 343(17):2963-70. PubMed ID: 18804200
[TBL] [Abstract][Full Text] [Related]
17. Online reverse phase-high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry separation and characterization of heparan sulfate, heparin, and low-molecular weight-heparin disaccharides derivatized with 2-aminoacridone.
Galeotti F; Volpi N
Anal Chem; 2011 Sep; 83(17):6770-7. PubMed ID: 21780812
[TBL] [Abstract][Full Text] [Related]
18. Characterization of di- and monosulfated, unsaturated heparin disaccharides with terminal N-sulfated 1,6-anhydro-beta-D-glucosamine or N-sulfated 1,6-anhydro-beta-D-mannosamine residues.
Mascellani G; Guerrini M; Torri G; Liverani L; Spelta F; Bianchini P
Carbohydr Res; 2007 May; 342(6):835-42. PubMed ID: 17280651
[TBL] [Abstract][Full Text] [Related]
19. Quantitative determination of disaccharide content in digested unfragmented heparin and low molecular weight heparin by direct-infusion electrospray mass spectrometry.
Camara JE; Satterfield MB; Nelson BC
J Pharm Biomed Anal; 2007 Apr; 43(5):1706-14. PubMed ID: 17275239
[TBL] [Abstract][Full Text] [Related]
20. Heparin sodium compliance to USP monograph: structural elucidation of an atypical 2.18 ppm NMR signal.
Mourier PA; Guichard OY; Herman F; Viskov C
J Pharm Biomed Anal; 2012; 67-68():169-74. PubMed ID: 22579602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
